Histology, IHC, ISH and Gene Expression Profiling

Epistem has access to human oncology tissue either provided by the customer or sourced locally, and a core capability to assist clients with their drug development decision-making process. Theraputic target validation can use:

• Histology
• Immunohistochemistry (IHC)
• In situ hybridisation (ISH)
• Highly sensitive gene expression profiling (qRT-PCR)

A tailored target validation programme can be set up to explore the expression of key target genes and proteins in human diseased tissue.